Treatment of Papillary Thyroid Cancer with Tumor ≤1 cm Confined to the Thyroid (cT1aN0M0)

This protocol addresses early-stage papillary thyroid carcinoma presenting as a small, organ-confined primary lesion with no evidence of spread to regional lymph nodes or distant sites.

Clinical scenario

Papillary thyroid carcinoma, primary tumor ≤1 cm (cT1a)
Confined to the thyroid — no extrathyroidal extension
No regional cervical lymph node metastasis (cN0)
No distant metastasis (cM0)

Active surveillance may be appropriate for select patients in this setting. Ultrasound-guided percutaneous ablation may also be considered as an alternative in selected individuals.

Approach — partial overview

Surgical resection remains a central management option for this presentation. The extent and precise indications for intervention depend on individual patient and tumor factors detailed in the full protocol.

Full regimen, selection criteria, and decision algorithm available via the structured protocol below.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1177/10507256251363120

Active surveillance may be offered as an appropriate management option for some patients with cT1aN0M0 PTCs.

Ultrasound-guided percutaneous ablation may be considered as an alternative to active surveillance or resection for cT1aN0M0 PTC in selected patients.

In patients undergoing active surveillance, surgical resection is indicated if there is evidence of new biopsy-proven lymph node metastases, growth of the primary tumor by ≥3 mm, distant metastases, evidence of extrathyroidal extension, posterior growth, when there is patient anxiety, inability to follow-up, and/or expressed preference for surgery.

View source ↗